Diversity Defeats Disease

In a pond, more amphibian species mean decreased chances of disease spread.

Written byRuth Williams
| 3 min read

Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share

Trematode-infected frog with limb deformitiesD. Herasimtschuk, Freshwaters IllustratedThe chance of a frog getting infected by a parasitic worm that causes limb deformities is less if it lives among a diverse array of pond mates that can also be infected, according to a study published today (February 13) in Nature. The report provides proof for the long-held theory that diversity drives down the spread of pathogens, and has implications beyond the pond, in human health and disease.

“This is the most complete study I’ve seen on biodiversity decreasing disease,” said Andrew Blaustein, a professor of zoology at Oregon State University, who was not involved in the study.

“The study is unusually comprehensive in combining field and lab and mesocosm—[controlled ecosystem]—studies,” agreed Rick Ostfeld, a disease ecologist at the Cary Institute of Ecosystem Studies, in Millbrook, New York, who also did not participate in the work. “It’s delightfully elegant in covering all the bases.”

According to a theory, known as the dilution effect, having a variety of host species to infect will actually reduce the chances that a parasite will spread. The idea is, hosts that are readily susceptible to infection will become diluted in the population by more resistant hosts as diversity ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here
Add The Scientist as a preferred source on Google

Add The Scientist as a preferred Google source to see more of our trusted coverage.

Related Topics

Meet the Author

  • ruth williams

    Ruth is a freelance journalist. Before freelancing, Ruth was a news editor for the Journal of Cell Biology in New York and an assistant editor for Nature Reviews Neuroscience in London. Prior to that, she was a bona fide pipette-wielding, test tube–shaking, lab coat–shirking research scientist. She has a PhD in genetics from King’s College London, and was a postdoc in stem cell biology at Imperial College London. Today she lives and writes in Connecticut.

    View Full Profile
Share
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Graphic of amino acid chains folded into proteins

Expi293™ PRO Expression System: Higher Yields Across a Wider Variety of Proteins

Thermo Fisher Logo